Publication | Closed Access

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study

Hematological MalignancyOncologyHematologyMyeloid NeoplasiaReal-life SettingPharmacotherapySingle-center Retrospective StudyMedicineRadiation OncologyHealth Sciences